GS
BNGO icon

GTS Securities’s Bionano Genomics BNGO Stock Holding History

GTS Securities’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-436
Closed -$49.4K – 3876
2023
Q4 		$49.4K Buy
+436
New +$45.5K ﹤0.01% 3832

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GTS Securities's BNGO Position: Q3 2024 in Review

GTS Securities sold out of Bionano Genomics (BNGO) in Q3 2024, closing a stake of 184 shares — an estimated $5.72K sold.

GTS Securities first reported a position in BNGO in Q2 2024 and held it in 1 quarter. The position peaked at $7.47K in Q2 2024. 47 funds tracked by Wall St. Rank hold BNGO as of Q3 2024.

  • GTS Securities reported no remaining Bionano Genomics position as of Q3 2024 after selling out during the quarter.
  • GTS Securities sold 184 Bionano Genomics shares in Q3 2024, an estimated $5.72K.
  • GTS Securities first reported a position in Bionano Genomics in Q2 2024 and held it in 1 quarter.
  • GTS Securities's Bionano Genomics position peaked at $7.47K in Q2 2024.
  • 47 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2024.

Based on GTS Securities's 13F filing for Q3 2024, filed 13 Nov 2024.